A new type of therapy that "edits" a gene in patients with a rare heart condition has been shown to be safe and effective, ...

Discover how inebilizumab reduces flares and improves remission rates in IgG4-related disease in this phase 3 clinical trial.

A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...

Imagine a world where doctors could give their patients a list of every clinical trial they are eligible to join.

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren's syndrome, a ...

SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular ...

Failing to receive the RMAT designation from the FDA for its early-stage Batten disease gene therapy, Neurogene tells ...

Indianapolis-based OrthoIndy treated the first patients with Theradaptive's OsteoAdapt SP spinal fusion implant as part of an ongoing clinical trial. The Phase I/II Oasis trial is asssing the safety ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia ...

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, releases the following letter to ...